Publications
SAFETY AND EXPOSURE OF BAVITUXIMAB IN PREVIOUSLY TREATED ASIAN AND NON-ASIAN NON-SMALL-CELL LUNG CANCER PATIENTS
Chinese Society of Clinical Oncology (CSCO)

September 11th, 2019

Working towards Precision Medicine for the Tumor Microenvironment
Society for Immunotherapy of Cancer (SITC)

November 6th-11th, 2019

A global phase II trial-in-progress with bavituximab plus pembrolizumab in patients with advanced gastric or gastroesophageal cancer
American Society of Clinical Oncology Gastrointestinal (ASCO GI)

January 23th-25th, 2020

A phase II clinical trial of the phosphatidylserine-targeting antibody, bavituximab, in combination with pembrolizumab in patients with advanced hepatocellular carcinoma
American Society of Clinical Oncology Gastrointestinal (ASCO GI)

January 23th-25th, 2020